(Q46123432)

19 December 2017

title

The association of plasma cysteine and gamma-glutamyltransferase with BMI and obesity (English)

1 reference

19 December 2017

0 references

2

Helga Refsum

1 reference

19 December 2017

Amany K Elshorbagy

1

1 reference

19 December 2017

A David Smith

series ordinal

3

1 reference

19 December 2017

Ian M Graham

series ordinal

4

1 reference

19 December 2017

publication date

12 February 2009

1 reference

19 December 2017

published in

Obesity

1 reference

19 December 2017

volume

17

1 reference

19 December 2017

issue

7

1 reference

19 December 2017

page(s)

1435-1440

1 reference

19 December 2017

Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Predictors of change in plasma total cysteine: longitudinal findings from the Hordaland homocysteine study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

PATHOLOGICAL FINDINGS IN HOMOCYSTINURIA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Dietary cysteine alleviates sucrose-induced oxidative stress and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Mammalian cysteine metabolism: new insights into regulation of cysteine metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Glutathione metabolism and its implications for health

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Gamma glutamyl transferase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Oxygen-induced pulmonary injury in gamma-glutamyl transpeptidase-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Reduced glutathione, gamma-glutamylcysteine, cysteine and gamma-glutamylglutamine in gamma-glutamyltransferase deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Plasma glutathione levels are independently associated with gamma-glutamyltransferase activity in subjects with cardiovascular risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Hepatic fat content-independent association of the serum level of gamma-glutamyltransferase with visceral adiposity, but not subcutaneous adiposity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

The associations of physical activity and adiposity with alanine aminotransferase and gamma-glutamyltransferase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Is serum gamma glutamyltransferase a marker of oxidative stress?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Elevated gamma-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

The Tromsø Study. Distribution and population determinants of gamma-glutamyltransferase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Body fat distribution, relative weight, and liver enzyme levels: a population-based study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

The association between cysteine, bone turnover, and low bone mass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Genetic background conversion ameliorates semi-lethality and permits behavioral analyses in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Cysteine-rich protein reverses weight loss in lung cancer patients receiving chemotherapy or radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Enzymes and metabolites of cysteine metabolism in nonhepatic tissues of rats show little response to changes in dietary protein or sulfur amino acid levels.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Methionine restriction decreases visceral fat mass and preserves insulin action in aging male Fischer 344 rats independent of energy restriction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Resting metabolic rate is not reduced in obese adults with Down syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

Homocysteine metabolism in children with Down syndrome: in vitro modulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.671

31 March 2020

Identifiers

DOI

10.1038/OBY.2008.671

1 reference

19 December 2017

PubMed ID

19214177

1 reference

19 December 2017